SC 13G/A | 2024-01-10 | FMR LLC | Cerevel Therapeutics Holdings, Inc. | 9,691,851 | 5.4% | EDGAR |
SC 13D/A | 2023-12-08 | BC Perception Holdings, LP | Cerevel Therapeutics Holdings, Inc. | 65,679,781 | 36.4% | EDGAR |
SC 13D/A | 2023-10-18 | PFIZER INC | Cerevel Therapeutics Holdings, Inc. | 27,349,211 | 15.4% | EDGAR |
SC 13D/A | 2023-10-18 | BC Perception Holdings, LP | Cerevel Therapeutics Holdings, Inc. | 65,679,781 | 36.5% | EDGAR |
SC 13D/A | 2023-10-17 | PERCEPTIVE ADVISORS LLC | Cerevel Therapeutics Holdings, Inc. | 10,965,193 | 6.2% | EDGAR |
SC 13D/A | 2023-04-25 | PERCEPTIVE ADVISORS LLC | Cerevel Therapeutics Holdings, Inc. | 9,918,068 | 6.3% | EDGAR |
SC 13D | 2023-04-21 | PERCEPTIVE ADVISORS LLC | Cerevel Therapeutics Holdings, Inc. | 10,088,385 | 6.4% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Cerevel Therapeutics Holdings, Inc. | 23,453,788 | 15.0% | EDGAR |
SC 13D/A | 2022-08-18 | BC Perception Holdings, LP | Cerevel Therapeutics Holdings, Inc. | 60,632,356 | 38.9% | EDGAR |
SC 13D/A | 2022-04-07 | PFIZER INC | Cerevel Therapeutics Holdings, Inc. | 27,349,211 | 18.5% | EDGAR |
SC 13D/A | 2022-03-03 | BC Perception Holdings, LP | Cerevel Therapeutics Holdings, Inc. | 60,632,356 | 41.0% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | Cerevel Therapeutics Holdings, Inc. | 19,509,813 | 13.2% | EDGAR |
SC 13D/A | 2021-09-17 | PFIZER INC | Cerevel Therapeutics Holdings, Inc. | 27,349,211 | 18.9% | EDGAR |
SC 13G | 2021-08-10 | FMR LLC | Cerevel Therapeutics Holdings, Inc. | 16,573,891 | 11.7% | EDGAR |
SC 13D/A | 2021-07-09 | PFIZER INC | Cerevel Therapeutics Holdings, Inc. | 27,349,211 | 19.4% | EDGAR |
SC 13D/A | 2021-07-09 | BC Perception Holdings, LP | Cerevel Therapeutics Holdings, Inc. | 60,632,356 | 42.9% | EDGAR |
SC 13G/A | 2021-06-10 | FEDERATED HERMES, INC. | Cerevel Therapeutics Holdings, Inc. | 2,233,333 | 1.8% | EDGAR |
SC 13G/A | 2021-04-09 | FEDERATED HERMES, INC. | Cerevel Therapeutics Holdings, Inc. | 1,950,000 | 10.2% | EDGAR |
SC 13G | 2021-02-12 | FEDERATED HERMES, INC. | Cerevel Therapeutics Holdings, Inc. | 1,235,033 | 6.3% | EDGAR |
SC 13G/A | 2020-12-10 | PRICE T ROWE ASSOCIATES INC /MD/ | Cerevel Therapeutics Holdings, Inc. | 3,639,190 | 2.8% | EDGAR |